Helen Torley's Net Worth

Helen Torley's net worth is estimated to be at least $9,733,994.29 as of 12/25/2024. CoreStreet's estimation of Helen Torley's net worth is based on their sale of stock and current holding of stock.

Helen Torley is CEO at Halozyme Therapeutics Inc. They have executed at least 18 trades of stock as per SEC Form 4 filings. Their most recent trade was for 10,000 units of HALO stock on 10/09/2024. Their biggest sale was on 08/12/2013 when they sold 9,311 units of Amgen Inc stock for $1,181,472.79. They typically trade 3 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $9,733,994.29
Most recent insider trade:
  • Oct. 9, 2024

Helen Torley's Insider Trading History

Halozyme Therapeutics IncTitleAmountPriceTypeTotal Value
Oct. 9, 2024
CEO10,000$52.58Sell$525,800.00
Sept. 25, 2024
CEO10,000$56.34Sell$563,400.00
Sept. 12, 2024
CEO10,000$59.20Sell$592,000.00
Sept. 10, 2024
CEO10,000$59.09Sell$590,900.00
Aug. 31, 2023
CEO10,000$42.82Sell$428,200.00
Aug. 29, 2023
CEO10,000$42.40Sell$424,000.00
Aug. 17, 2023
CEO10,000$43.18Sell$431,800.00
July 26, 2023
CEO10,000$42.69Sell$426,900.00
March 9, 2023
CEO10,000$42.73Sell$427,300.00
March 7, 2023
CEO10,000$45.47Sell$454,700.00
Feb. 16, 2023
CEO11,061$49.26Sell$544,864.86
Feb. 8, 2023
CEO10,000$51.36Sell$513,600.00
Jan. 19, 2023
CEO10,000$52.41Sell$524,100.00
Dec. 15, 2022
CEO10,000$57.37Sell$573,700.00
Nov. 17, 2022
CEO10,000$52.15Sell$521,500.00
Amgen IncTitleAmountPriceTypeTotal Value
Aug. 12, 2013
EVP9,311$126.89Sell$1,181,472.79
May 13, 2013
EVP8,250$98.13Sell$809,572.50
Oct. 4, 2012
EVP2,314$86.51Sell$200,184.14